HOTH: Hoth Therapeutics, Inc. Stock

by  •  • Comments Off on HOTH: Hoth Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 5.24
Enterprise Value ($M) -4.05
Book Value ($M) 8.82
Book Value / Share 2.00
Price / Book 0.59
NCAV ($M) 8.72
NCAV / Share 1.98
Price / NCAV 0.60

Profitability (mra)
Return on Invested Capital (ROIC) -0.88
Return on Assets (ROA) -0.58
Return on Equity (ROE) -0.66

Liquidity (mrq)
Quick Ratio 13.89
Current Ratio 13.89

Balance Sheet (mrq) ($M)
Current Assets 9.43
Assets 9.52
Liabilities 0.70
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -7.69
Net Income -7.85
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -8.45
Cash from Investing 0.00
Cash from Financing 11.32

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 4.99 57.96

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended: September 30, 2023 ☐ TRANSITION REP
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended: June 30, 2023 ☐ TRANSITION REPORT P
2023-05-15 10-Q Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-18 3,523 19,203 18.35
2024-04-17 7,914 23,590 33.55
2024-04-16 17,231 75,453 22.84
2024-04-15 17,671 55,268 31.97

(click for more detail)

Similar Companies
GYRE – Gyre Therapeutics, Inc. HEPA – Hepion Pharmaceuticals, Inc.
HOOK – HOOKIPA Pharma Inc. HRTX – Heron Therapeutics, Inc.
ICCC – ImmuCell Corporation


Financial data and stock pages provided by
Fintel.io